S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
S&P 500   3,271.03 (-3.53%)
DOW   26,519.95 (-3.43%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
Log in
NASDAQ:CCRN

Cross Country Healthcare Price Target, Predictions & Analyst Ratings

$6.89
-0.13 (-1.85 %)
(As of 10/28/2020 04:30 PM ET)
Add
Compare
Today's Range
$6.65
Now: $6.89
$7.05
50-Day Range
$5.78
MA: $6.69
$7.65
52-Week Range
$4.50
Now: $6.89
$13.42
Volume223,213 shs
Average Volume265,118 shs
Market Capitalization$258.83 million
P/E RatioN/A
Dividend YieldN/A
Beta1.12

Analyst Ratings

Cross Country Healthcare (NASDAQ:CCRN) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for Cross Country Healthcare in the last 12 months. Their average twelve-month price target is $7.63, predicting that the stock has a possible upside of 10.67%. The high price target for CCRN is $9.00 and the low price target for CCRN is $7.00. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
CCRN Consensus Rating: HoldHoldHoldBuy
CCRN Consensus Rating Score: 2.002.252.332.50
CCRN Analyst Ratings: 1 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
CCRN Consensus Price Target: $7.63$7.67$8.00$9.50
CCRN Price Target Upside: 10.67% upside14.48% upside32.23% upside18.40% upside

Cross Country Healthcare (NASDAQ:CCRN) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cross Country Healthcare (NASDAQ:CCRN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/8/2020Bank of AmericaInitiated CoverageUnderperform$7.50High
8/17/2020OppenheimerReiterated RatingHold ➝ NeutralMedium
8/12/2020Barrington ResearchReiterated RatingBuy$9.00Medium
8/6/2020Credit Suisse GroupBoost Price TargetNeutral$6.50 ➝ $7.00High
5/8/2020SunTrust BanksLower Price TargetHold$9.00 ➝ $7.00Low
2/28/2019BMO Capital MarketsLower Price TargetMarket Perform ➝ Market Perform$10.00 ➝ $8.00Medium
11/2/2018Lake Street CapitalUpgradeHold ➝ Buy$10.00 ➝ $12.00High
10/2/2018StephensInitiated CoverageEqual WeightLow
8/1/2018Cantor FitzgeraldReiterated RatingNeutral ➝ Hold$11.00 ➝ $10.00High
3/1/2018BenchmarkDowngradeBuy ➝ Hold$19.00High
2/1/2018Jefferies Financial GroupInitiated CoverageHold ➝ Hold$15.00Low
(Data available from 10/28/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 10/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.